Leap Therapeutics, Inc. was founded in 2012 to develop innovative therapies to treat some of the toughest cancers. After assembling a world-class life sciences team with deep experience in oncology drug development, the Company has since acquired, developed or in-licensed several clinically and commercially durable compounds, as well as recruited a number of strategic and corporate partners to help bring these treatments to market.
